Session 6 - Innovating molecular diagnostic technologies for the clinic
Tuesday, 21 April, 2015 - 08:30 to 10:00
Chair
Tania Bubela
University of Alberta
Pre-Discussion Presentation
Director of Commercialization Research, Personalized Cellular Immunotherapy Project, Hôpital Maisonneuve Rosemont
Panelists
Medical Director, Public Health Serology, Provinical Health Services Laboratories, BC Centre for Disease Control
This session will explore challenges in late-stage molecular diagnostics development, current best practices and strategies for enabling innovation in molecular diagnostics and personalized medicine. Stakeholder perspectives related to IP protection, technology transfer, investment, commercialization and health care system adoption will be shared and discussed, including both private- and public-sector views. To allow for interactive discussion between the panel members and the audience, the session will be run with minimal time devoted to formal presentations.